フィルター
4 件の結果が “16326” で取得されました
並べ替える:
アルファベット順(A-Z)
ベストセラー
Inhbe-KO
製品ID :
C002036
系統:
C57BL/6NCya
状況:
説明:
Inhibin βE subunit (INHBE) is a member of the transforming growth factor-β (TGF-β) superfamily, highly specifically expressed in liver cells. The precursor protein of INHBE generates the inhibin β subunit after proteolytic processing. This protein is associated with various cellular processes, including cell proliferation, apoptosis, immune response, and hormone secretion. During the development of obesity and diabetes, the expression of INHBE protein inhibits the proliferation and growth of relevant cells in the pancreas and liver. Research has found a positive correlation between INHBE expression in the liver and insulin resistance and body mass index (BMI), suggesting that INHBE may be a liver factor in altering systemic metabolic status under conditions of obesity-related insulin resistance [1].
The studies conducted by Alnylam Pharmaceuticals and the Regeneron Genetics Center (RGC), respectively, revealed the close relationship between INHBE and fat regulation. The research demonstrated that rare loss-of-function variants in INHBE may protect the liver from the impact of inflammation, abnormal blood lipids, and type 2 diabetes by promoting healthy fat storage. Patients carrying such mutations exhibit more normal fat distribution, significantly reduced abdominal fat, improved metabolic conditions, and a decreased risk of cardiovascular diseases and type 2 diabetes [2-4]. These findings suggest that INHBE is a liver-specific negative regulator of fat storage. Inhibiting the expression of INHBE genes and proteins may be a potential strategy for treating metabolic disorders related to improper fat distribution and storage.
The Inhbe-KO mouse is a gene knockout (KO) model. Exons 1 to 2 of the mouse Inhbe gene (ortholog of human INHBE) were deleted via gene editing technology. This model can be used for research on obesity and metabolic disorders associated with abnormal fat distribution and lipid storage.
Inhibin βE subunit (INHBE) is a member of the transforming growth factor-β (TGF-β) superfamily, highly specifically expressed in liver cells. The precursor protein of INHBE generates the inhibin β subunit after proteolytic processing. This protein is associated with various cellular processes, including cell proliferation, apoptosis, immune response, and hormone secretion. During the development of obesity and diabetes, the expression of INHBE protein inhibits the proliferation and growth of relevant cells in the pancreas and liver. Research has found a positive correlation between INHBE expression in the liver and insulin resistance and body mass index (BMI), suggesting that INHBE may be a liver factor in altering systemic metabolic status under conditions of obesity-related insulin resistance [1].
The studies conducted by Alnylam Pharmaceuticals and the Regeneron Genetics Center (RGC), respectively, revealed the close relationship between INHBE and fat regulation. The research demonstrated that rare loss-of-function variants in INHBE may protect the liver from the impact of inflammation, abnormal blood lipids, and type 2 diabetes by promoting healthy fat storage. Patients carrying such mutations exhibit more normal fat distribution, significantly reduced abdominal fat, improved metabolic conditions, and a decreased risk of cardiovascular diseases and type 2 diabetes [2-4]. These findings suggest that INHBE is a liver-specific negative regulator of fat storage. Inhibiting the expression of INHBE genes and proteins may be a potential strategy for treating metabolic disorders related to improper fat distribution and storage.
The Inhbe-KO mouse is a gene knockout (KO) model. Exons 1 to 2 of the mouse Inhbe gene (ortholog of human INHBE) were deleted via gene editing technology. This model can be used for research on obesity and metabolic disorders associated with abnormal fat distribution and lipid storage.
Ipo4-flox
製品ID :
S-CKO-16326
系統:
C57BL/6JCya
状況:
説明:
Ipo4 is located on chromosome 14 of mice. SgRNA and ssDNA were designed using Nuclease Technology; Ipo4 conditional knockout mice were obtained by high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Ipo4 is located on chromosome 14 of mice. SgRNA and ssDNA were designed using Nuclease Technology; Ipo4 conditional knockout mice were obtained by high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Inhbe-KO
製品ID :
S-KO-20448
系統:
C57BL/6JCya
状況:
説明:
Inhbe is located on chromosome 10 of mice. Nuclease Technology was used to design sgRNA; Inhbe knockout mice were obtained by applying high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Inhbe is located on chromosome 10 of mice. Nuclease Technology was used to design sgRNA; Inhbe knockout mice were obtained by applying high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Inhbe-flox
製品ID :
S-CKO-03128
系統:
C57BL/6JCya
状況:
説明:
Inhbe is located on chromosome 10 of mice. SgRNA and ssDNA were designed using Nuclease Technology; Inhbe conditional knockout mice were obtained by high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Inhbe is located on chromosome 10 of mice. SgRNA and ssDNA were designed using Nuclease Technology; Inhbe conditional knockout mice were obtained by high-throughput electroporation of fertilized eggs. After sexual maturity, sperm were collected for cryopreservation.
Items: 1 to 4 of 4
1
